Global Stem Cells Group announced plans to participate in the Spanish Society of Cosmetic Medicine and Surgery (SEMCC) Mediterannean Conference XXIV of Therapeutic Confrontations in Medicine and Cosmetic Surgery in Sitges, Barcelona, Spain, May 6-8 2016. Members of the GSCG Faculty will represent the biotech company in Barcelona.
Global Stem Cells Group Faculty members will represent the biotech company at the Spanish Society of Cosmetic Medicine and Surgery (SEMCC) Mediterannean Conference XXIV of Therapeutic Confrontations in Medicine and Cosmetic Surgery in Sitges, Barcelona, Spain, May 6-8 2016.
2016 will mark the third consecutive year Global Stem Cells Group will collaborate with SEMCC President Victor Garcia Gimenez on the conference, designed to advance the aesthetic applications of stem cells. The conference will be followed by an extensive six-hour, hands-on stem cell training class presented by GSCG subsidiary Stem Cell Training, Inc. to provide participating physicians with state-of-the-art techniques for isolating and re-integrating adipose-derived stem cells, along with clinical protocols.
Increasing interest in regenerative medicine among the medical community, along with recent advances in stem cell therapies have motivated Global Stem Cells Group and SEMCC to create programs like this one, designed to promote the most recent studies and supporting investigative protocols for clinical applications. Relevant members of the featured faculties will dictate theory portions of the symposium.
Joining the Global Stem Cells Group Faculty will be: Prof. Angel Raya, M.D., Professor at the Catalan Institute for Research and Advanced Studies (ICREA), Researcher, Home Group Power Control Stem Cell Institute, Bioengineering of Catalonia (IBEC), and Director of the Center for Regenerative Medicine in Barcelona (CMRB); and Prof. Anna Veiga, Biological Sciences Professor at the Pompeu Fabra University and Director of the Stem Cell Bank Center of Regenerative Medicine in Barcelona (CMRB).
Special guests will include: Pier A. Bacci, M.D. (Italy); Maurizio Ceccarelli, M.D. (Italy); Julio Ferreira, M.D. (Argentina); Joan X. Fontdevila, M.D., (Spain); Alfredo Hoyos, M.D. (Colombia); Max Lafontan, M.D. (France); José María Martínez, M.D. (Spain); Maria Jesús Moreno, M.D. (Spain); Kotaro Yoshimura, M.D. (Japan); Patrick Micheels, M.D. (Switzerland); Greg Muller, M.D. (USA); Bruno Bioulac, M.D. (Germany); Jani Van Loghen, M.D. (Netherlands); Elena Rumyantseva (France) and others.
The conference will be held at the Hotel Melia Sitges.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for cutting-edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/